BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

490 related articles for article (PubMed ID: 18535182)

  • 1. Role of the peroxynitrite-poly(ADP-ribose) polymerase pathway in human disease.
    Pacher P; Szabo C
    Am J Pathol; 2008 Jul; 173(1):2-13. PubMed ID: 18535182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of poly(ADP-ribose) polymerase 1 (PARP-1) in cardiovascular diseases: the therapeutic potential of PARP inhibitors.
    Pacher P; Szabó C
    Cardiovasc Drug Rev; 2007; 25(3):235-60. PubMed ID: 17919258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poly(ADP-ribose) Polymerase (PARP) and PARP Inhibitors: Mechanisms of Action and Role in Cardiovascular Disorders.
    Henning RJ; Bourgeois M; Harbison RD
    Cardiovasc Toxicol; 2018 Dec; 18(6):493-506. PubMed ID: 29968072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the peroxynitrite-poly (ADP-ribose) polymerase pathway in the pathogenesis of liver injury.
    Gero D; Szabó C
    Curr Pharm Des; 2006; 12(23):2903-10. PubMed ID: 16918420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Peroxynitrite-Induced Activation of Poly(ADP-Ribose) Polymerase (PARP) in Circulatory Shock and Related Pathological Conditions.
    Islam BU; Habib S; Ali SA; Moinuddin ; Ali A
    Cardiovasc Toxicol; 2017 Oct; 17(4):373-383. PubMed ID: 27990620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pathogenesis of diabetic complications: the role of DNA injury and poly(ADP-ribose) polymerase activation in peroxynitrite-mediated cytotoxicity.
    Kiss L; Szabó C
    Mem Inst Oswaldo Cruz; 2005 Mar; 100 Suppl 1():29-37. PubMed ID: 15962096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitric oxide-peroxynitrite-poly(ADP-ribose) polymerase pathway in the skin.
    Virág L; Szabó E; Bakondi E; Bai P; Gergely P; Hunyadi J; Szabó C
    Exp Dermatol; 2002 Jun; 11(3):189-202. PubMed ID: 12102657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of poly(ADP-ribose) synthetase in inflammation and ischaemia-reperfusion.
    Szabó C; Dawson VL
    Trends Pharmacol Sci; 1998 Jul; 19(7):287-98. PubMed ID: 9703762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of nitrosative stress and poly(ADP-ribose) polymerase activation in myocardial reperfusion injury.
    Szabó G; Bährle S
    Curr Vasc Pharmacol; 2005 Jul; 3(3):215-20. PubMed ID: 16026318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poly (ADP-ribose) polymerase activation and circulatory shock.
    Szabó C
    Novartis Found Symp; 2007; 280():92-103; discussion 103-7, 160-4. PubMed ID: 17380790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poly(ADP-ribose) polymerase inhibitors: new pharmacological functions and potential clinical implications.
    de la Lastra CA; Villegas I; Sánchez-Fidalgo S
    Curr Pharm Des; 2007; 13(9):933-62. PubMed ID: 17430191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Superoxide, NO, peroxynitrite and PARP in circulatory shock and inflammation.
    Esposito E; Cuzzocrea S
    Front Biosci (Landmark Ed); 2009 Jan; 14(1):263-96. PubMed ID: 19273067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The therapeutic potential of poly(ADP-ribose) polymerase inhibitors.
    Virág L; Szabó C
    Pharmacol Rev; 2002 Sep; 54(3):375-429. PubMed ID: 12223530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peroxynitrite-induced cytotoxicity: mechanism and opportunities for intervention.
    Virág L; Szabó E; Gergely P; Szabó C
    Toxicol Lett; 2003 Apr; 140-141():113-24. PubMed ID: 12676457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetic endothelial dysfunction: role of reactive oxygen and nitrogen species production and poly(ADP-ribose) polymerase activation.
    Soriano FG; Virág L; Szabó C
    J Mol Med (Berl); 2001 Aug; 79(8):437-48. PubMed ID: 11511974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poly(ADP-ribose) polymerase activation by reactive nitrogen species--relevance for the pathogenesis of inflammation.
    Szabó C
    Nitric Oxide; 2006 Mar; 14(2):169-79. PubMed ID: 16111903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of free radicals and poly(ADP-ribose)polymerase-1 in the development of spinal cord injury: new potential therapeutic targets.
    Genovese T; Cuzzocrea S
    Curr Med Chem; 2008; 15(5):477-87. PubMed ID: 18289003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of redox signaling and poly (adenosine diphosphate-ribose) polymerase activation in vascular smooth muscle cell growth inhibition by nitric oxide and peroxynitrite.
    Huang J; Lin SC; Nadershahi A; Watts SW; Sarkar R
    J Vasc Surg; 2008 Mar; 47(3):599-607. PubMed ID: 18295111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of nitrosative stress and activation of poly(ADP-ribose) polymerase-1 in cardiovascular failure associated with septic and hemorrhagic shock.
    Evgenov OV; Liaudet L
    Curr Vasc Pharmacol; 2005 Jul; 3(3):293-9. PubMed ID: 16026325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poly(ADP-ribose) polymerase-mediated cell injury in acute renal failure.
    Devalaraja-Narashimha K; Singaravelu K; Padanilam BJ
    Pharmacol Res; 2005 Jul; 52(1):44-59. PubMed ID: 15911333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.